Substance Use Disorder

Pelago, a digital clinic partner to U.S. businesses and health plans for substance use management, announced Tuesday the addition of cannabis to its specialized substance use disorder (SUD) treatments. The new program, which will be fully implemented by Q3 2024, expands the New York-headquartered...

The Centers for Disease Control and Prevention (CDC) recently published a study highlighting a concerning trend among American teenagers: the increasing role of stress and anxiety in driving substance use.  The report, covering data from 2014 to 2022, sheds light on the motivations behind...

Boston’s Brigham and Women’s Hospital received a $7.5 million donation from Eliza Dushku Palandjian, her husband and Intercontinental Real Estate Corporation’s CEO Peter Palandjian toward supporting substance use disorders (SUDs) treatments. Out of the total donated, $5...

On this new Psychedelics Exclusive podcast, TDR Founder Shadd Dales interviews Awakn Life Sciences Corp. (OTC: AWKNF) CEO Anthony Tennyson, as his company moves closer towards a Phase III clinical trial exploring the use of ketamine-assisted therapy to treat severe Alcohol Use...